HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 36 filers reported holding HORIZON PHARMA INVT LTD in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,751,000 | -73.7% | 3,000,000 | -73.3% | 0.22% | -67.9% |
| Q4 2017 | $10,463,000 | -28.7% | 11,250,000 | -30.8% | 0.68% | -29.4% |
| Q3 2017 | $14,676,000 | -37.5% | 16,250,000 | -40.4% | 0.96% | -40.4% |
| Q2 2017 | $23,486,000 | -38.9% | 27,250,000 | -35.5% | 1.60% | -24.0% |
| Q1 2017 | $38,448,000 | -9.7% | 42,250,000 | -5.6% | 2.11% | +2.6% |
| Q4 2016 | $42,568,000 | +4.2% | 44,750,000 | +5.9% | 2.06% | +9.9% |
| Q3 2016 | $40,850,000 | +39.8% | 42,250,000 | +31.0% | 1.87% | +16.6% |
| Q2 2016 | $29,227,000 | +61.5% | 32,250,000 | +51.8% | 1.61% | +61.5% |
| Q1 2016 | $18,099,000 | – | 21,250,000 | – | 1.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 136,032,000 | $150,514,000 | 5.41% |
| SYMPHONY ASSET MANAGEMENT LLC | 16,000,000 | $17,780,000 | 3.72% |
| CSS LLC/IL | 12,427,000 | $13,791,000 | 0.79% |
| SSI INVESTMENT MANAGEMENT LLC | 8,793,000 | $9,740,000 | 0.72% |
| Worth Venture Partners, LLC | 1,103,000 | $1,227,000 | 0.68% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 29,900,000 | $33,208,000 | 0.64% |
| Sonora Investment Management, LLC | 4,840,000 | $5,374,000 | 0.60% |
| Empyrean Capital Partners, LP | 8,000,000 | $8,875,000 | 0.40% |
| DLD Asset Management, LP | 5,500,000 | $6,129,000 | 0.26% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 12,500 | $10,496,000 | 0.25% |